A practical reference on LC-MS/MS: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-08-22 and is reviewed periodically as new material appears.
Analytical measurement of NMN typically uses reversed-phase high-performance liquid chromatography with ultraviolet detection near 260 nm. Mass spectrometry, often coupled to liquid chromatography, provides sensitive quantification and confirmatory identification in biological matrices. Nuclear magnetic resonance spectroscopy is used to verify molecular structure and distinguish related nucleotides. Because NMN is polar and poorly retained on conventional reversed-phase columns, ion-pairing reagents or hydrophilic interaction chromatography are sometimes employed. Reported purity values depend on the chosen method, calibration standard, and whether related substances are resolved.
Stability studies indicate that NMN is sensitive to heat, light, and pH extremes. In aqueous solution, hydrolysis can cleave the phosphate linkage or convert NMN to related nicotinamide derivatives, with degradation accelerating at elevated temperatures and alkaline conditions. Solid material is generally more stable when kept dry and cold, and research-grade supplies are often stored at minus twenty degrees Celsius or lower, protected from light and moisture. Repeated freeze-thaw cycles of solutions can promote degradation, so aliquoting is a common laboratory practice. The exact shelf life depends on purity, counterion, packaging, and storage history.
Quality control for NMN focuses on identity, purity, and the absence of harmful contaminants. Certificates of analysis may report high-performance liquid chromatography purity, mass spectrometry identity, residual solvents, heavy metals, and microbial limits, depending on grade and intended use. Because NMN can exist as different isomers, salts, or hydrates, specification sheets should state the exact form being tested. There is no single globally harmonized purity standard for NMN products. Open questions include which degradation products are most relevant under real-world storage and how analytical results from different laboratories can be compared reliably.
Laboratory identification of NMN usually relies on chromatographic separation coupled with ultraviolet or mass spectrometric detection. High-performance liquid chromatography with UV absorbance can quantify the compound against a reference standard, while liquid chromatography-tandem mass spectrometry offers lower detection limits and better specificity in complex matrices. Nuclear magnetic resonance spectroscopy can confirm structural identity and isomeric form. Ion chromatography or capillary electrophoresis may be used to identify counterions such as sodium. Method validation includes accuracy, precision, linearity, and limits of detection.
Stability testing examines how temperature, humidity, light, and pH affect NMN over time. The compound is generally stored cold, often at minus twenty degrees Celsius or lower, in a desiccated container protected from light. Aqueous solutions tend to be less stable than dry powder because hydrolysis and dephosphorylation can occur, potentially forming nicotinamide riboside or other degradation products. Stress studies may expose samples to heat, acid, base, oxidation, and strong light to identify likely degradation pathways. Results from such studies help define shelf life and handling recommendations, though exact stability depends on formulation and packaging.
| Property | Value | Notes |
|---|---|---|
| Typical purity assay | HPLC-UV or LC-MS | Purity may be reported as area percent or weight percent. |
| Identification methods | NMR, high-resolution MS, UV spectroscopy | Used together for structural confirmation. |
| Storage temperature | -20 °C or below, desiccated | Limits hydrolysis and microbial growth. |
| Light sensitivity | Protect from light | Amber glass or opaque containers reduce photodegradation. |
| Common synonyms | Nicotinamide mononucleotide, beta-NMN, NMN | Synonym use varies by isomer and salt form. |
NMN is generally handled as a hygroscopic and light-sensitive solid in laboratory settings. Recommended storage is typically at -20°C or below, often under desiccation and protected from light. Aqueous solutions are less stable than the solid and may degrade through hydrolysis or other pathways, so fresh preparation is common for analytical work. Repeated freeze-thaw cycles can reduce sample integrity. Stability depends on pH, temperature, buffer composition, and the presence of metal ions, so specific shelf-life values should be determined experimentally rather than assumed.
Quality control for NMN samples often includes purity determination by HPLC, identity confirmation by mass spectrometry or NMR, and water content measurement by Karl Fischer titration. Certificates of analysis may report residual solvents, heavy metals, and microbial limits depending on the intended use. Purity values are method-dependent, so a stated percentage should be interpreted alongside the analytical procedure and detection wavelength. Reference standards help ensure that retention times and spectral data are comparable across laboratories. Researchers increasingly request independent verification because supply chains for specialty chemicals can vary in documentation.
Analytical identification of NMN usually combines chromatographic separation with mass spectrometric detection. High-performance liquid chromatography coupled to tandem mass spectrometry is common for quantifying NMN in biological matrices and finished materials. Because NMN and related nucleotides share similar masses and retention behavior, method development must resolve potential interferences such as nicotinamide riboside and NAD+. Ultraviolet detection at approximately 260 nm can be used for purity checks when concentrations are sufficient. Nuclear magnetic resonance spectroscopy provides structural confirmation and can distinguish anomeric forms.
Stability testing examines how temperature, humidity, light, and pH affect NMN over time. The compound is generally considered hygroscopic and may degrade faster in aqueous solution than in dry powder form. Phosphate esters can hydrolyze under strongly acidic or alkaline conditions, and elevated temperatures accelerate such reactions. For storage, sealed containers at low temperature with desiccant are typical laboratory practices. Stability-indicating methods should separate NMN from its degradation products, including nicotinamide and nicotinamide riboside, so that purity loss can be tracked accurately.
Quality control for NMN materials typically includes identity, assay, impurity, and residual solvent tests. Certificates of analysis may report HPLC purity, water content, heavy metals, and microbial limits depending on the intended use. Because commercial NMN is sold as a research chemical or ingredient rather than a standardized drug in many jurisdictions, specifications can vary between suppliers. Independent verification can involve comparing retention time, mass spectrum, and NMR data against a reference standard. Open questions remain about how best to standardize purity claims and biological potency across different production methods.
Identity and purity are usually assessed with complementary methods. Nuclear magnetic resonance spectroscopy can confirm the molecular structure and distinguish anomeric forms. High-performance liquid chromatography with ultraviolet detection or mass spectrometry is common for assay and related-substance testing. Mass spectrometry also supports trace quantification in biological samples, often with isotope-labeled internal standards. Because NMN lacks a strong chromophore, some ultraviolet methods require careful wavelength selection or derivatization, and laboratories may validate each approach for its intended matrix.
Commercial NMN is produced through enzymatic or chemical routes, and the resulting material can vary in purity, counterion, and residual solvent content. Buyers typically rely on certificates of analysis, but independent verification through third-party laboratories provides stronger assurance. Regulatory treatment differs by country; in the United States, NMN has been subject to shifting guidance about its status as a dietary supplement, while other markets permit sales under local rules. No universal pharmacopeial monograph exists for NMN, so specifications often come from suppliers, research protocols, or regional requirements.
Solid NMN is generally handled as a moisture-sensitive compound. Dry material stored desiccated at low temperature, protected from light, tends to remain stable for extended periods. Aqueous solutions are less stable and can undergo hydrolysis, especially at elevated temperature or alkaline pH. The anomeric form also matters: beta-NMN is the naturally occurring form, while alpha-NMN can appear as a synthetic impurity. Purity and storage conditions therefore influence both analytical results and experimental reproducibility.
=== Wound duration === For chronic wounds: time the current wound has been present, is it a recurring wound, how many times it has recurred in the past, how long it took to heal each time. For acute wounds: when the wound was first acquired before the clinician visit.
== Causes == SASP expression is induced by a number of transcription factors, including MLL1 (KMT2A), C/EBPβ, and NF-κB. NF-κB has been referred to as the master transcription factor controlling SASP expression. NF-κB and the enzyme CD38 are mutually activating. NF-κB is expressed as a result of inhibition of autophagy-mediated degradation of the transcription factor GATA4. GATA4 is activated by the DNA damage response factors, which induce cellular senescence. SASP is both a promoter of DNA damage response and a consequence of DNA damage response, in an autocrine and paracrine manner. Aberrant oncogenes, DNA damage, and oxidative stress induce mitogen-activated protein kinases, which are the upstream regulators of NF-κB. Demethylation of DNA packaging protein Histone H3 (H3K27me3) can lead to up-regulation of genes controlling SASP. mTOR (mammalian target of rapamycin) is also a key initiator of SASP. Interleukin 1 alpha (IL1A) is found on the surface of senescent cells, where it contributes to the production of SASP factors due to a positive feedback loop with NF-κB. Translation of mRNA for IL1A is highly dependent upon mTOR activity. mTOR activity increases levels of IL1A, mediated by MAPKAPK2. mTOR inhibition of ZFP36L1 prevents this protein from degrading transcripts of numerous components of SASP factors. Inhibition of mTOR supports autophagy, which can generate SASP components.
Baroness Louise Casey's report into the standards and culture of the Metropolitan Police is published, and describes critical failings, such as discrimination, the organisation's inability to police itself, failings towards women and children, and the loss of public confidence in the service. 22 March Data released for February shows that inflation increased from 10.1% to 10.4%, largely due to an increase in the cost of fresh food (particularly vegetables), non-alcoholic drinks, restaurant meals, and women's clothes. A major incident is declared, with 35 injuries reported, after the 76m-long RV Petrel research vessel tips over at a dock in Leith. Boris Johnson gives evidence to the cross-party Privileges Committee, relating to his conduct during Partygate. He insists that he "did not lie" to the House of Commons and always made statements in good faith. MPs back Rishi Sunak's new Brexit deal for Northern Ireland by 515 votes to 29. Scotland's First Minister, Nicola Sturgeon, issues a "sincere, heartfelt and unreserved" apology to people affected by the practice of forced adoption in Scotland during the 1950s, 1960s and 1970s. The RMT call off two strikes planned by staff at 14 train operators that were scheduled for 30 March and 1 April following discussions with the Rail Delivery Group. Prime Minister Rishi Sunak publishes details of his tax returns following calls for him to be more transparent about his finances. 23 March The Bank of England raises its key interest rate for the 11th consecutive time, from 4% to 4.25%, in response to the unexpected growth of inflation.
Sources: en.wikipedia.org
A short abstract in 1943 followed by a detailed article in 1944 described the use of filter paper as the stationary phase for performing chromatography on amino acids: paper chromatography. By 1947, Martin, Synge and their collaborators had applied this method (along with Fred Sanger's reagent for identifying N-terminal residues) to determine the pentapeptide sequence of Gramicidin S. These and related paper chromatography methods were also foundational to Fred Sanger's effort to determine the amino acid sequence of insulin. Martin and Synge were awarded the 1952 Nobel Prize in Chemistry "for their invention of partition chromatography".
== Plastination exhibitions == For the first 20 years, plastination was used to preserve small specimens for medical study. In the early 1990s, the equipment was developed to make plastinating whole body specimens possible, each specimen taking up to 1,500-man-hours to prepare. The first exhibition of whole bodies was displayed by von Hagens in Japan in 1995. Over the next two years, von Hagens developed the Körperwelten (Body Worlds) public exhibitions, showing whole bodies plastinated in lifelike poses and dissected to show various structures and systems of human anatomy. The earliest exhibitions were presented in the Far East and in Germany, and Gunther von Hagens' exhibitions have subsequently been hosted by museums and venues in more than 50 cities worldwide, attracting more than 29 million visitors. Gunther von Hagens' Body Worlds exhibitions are the original, precedent-setting public anatomical exhibitions of real human bodies, and the only anatomical exhibits that use donated bodies, willed by donors to the Institute for Plastination for the express purpose of serving the Body Worlds mission to educate the public about health and anatomy. To date, more than 10,000 people have agreed to donate their bodies to Institute for Plastination. In 2004, Premier Exhibitions began their "Bodies Revealed" exhibition in Blackpool, England, which ran from August through October 2004. In 2005 and 2006, the company opened their "Bodies Revealed" and "Bodies...The Exhibition" in Seoul, Tampa, and New York City.
Since irregularities in the menstrual cycle are normal shortly after menarche and during perimenopause, the age of the individual and the time since menarche need to be taken into account. Menstrual cycles are considered irregular in the following cases:
Wartime conditions, including German bombing, made progress difficult. The 55-litre (12 imp gal) milk churns needed for shipment were in short supply, and special arrangements were made with the Ministry of Supply. The brew was initially despatched by rail to minimise the use of rationed petrol. The first 680 litres (150 imp gal) of brew, containing 6.1 million units at 9 units per mL, were delivered to Florey on 28 October 1942. Kemball, Bishop & Co. built an extraction plant, which became operational on 24 November 1943. In the meantime, Imperial Chemical Industries (ICI) had established a small production unit at its plant in Blackley and had begun shipments in December 1941. In May 1942, production moved to a purpose-built plant at Trafford Park, which initially produced two million Oxford units of penicillin per week. Production was ramped up to sixty million units per week by the time the plant was closed in March 1944; production shifted thereafter to a new plant that produced 300 million units per week. In 1947 ICI decided to construct a new plant to produce 32,000 litres (7,000 imp gal) of penicillin per day by the deep submergence method. Glaxo Laboratories opened a small production plant at Greenford in December 1942 that produced 70 litres of penicillin broth per week. In February 1943, it opened a second plant at Aylesbury. Initially it used the techniques developed at Oxford, but in September 1943 it switched to using corn steep liquor as a medium, and switched to using the NRRL 1249.B21 strain of mould provided by Coghill.
Sources: en.wikipedia.org
Parathyroid hormone (PTH), also known as parathormone or parathyrin, is a peptide hormone secreted by the parathyroid glands. It plays a critical role in regulating serum calcium and phosphate levels through its actions on bone, kidneys, and the small intestine. PTH increases serum calcium levels and is opposed by calcitonin. It also promotes the synthesis of calcitriol, the active form of vitamin D. PTH is secreted in response to low blood serum calcium (Ca2+) levels and is a key regulator of bone remodeling, the continuous process of bone resorption and formation. PTH indirectly stimulates osteoclast activity, promoting the release of calcium from the bone matrix to restore serum calcium levels. The bones serve as a reservoir of calcium, releasing it as needed to maintain homeostasis in the face of fluctuating metabolism, stress, and nutritional status. Produced primarily by the chief cells of the parathyroid glands, PTH is a polypeptide prohormone (precursor to a hormone) consisting of 84 amino acids and has a molecular mass of approximately 9500 Da. Its gene is located on chromosome 11 in humans. PTH exerts its biological effects via two main receptors. The Parathyroid hormone 1 receptor, activated by the 34 N-terminal amino acids of PTH, is highly expressed in bone and kidney cells. The Parathyroid hormone 2 receptor is predominantly found in the central nervous system, pancreas, testes, and placenta. The hormone has a short half-life of approximately 4 minutes.
== History == John B. Glen, a veterinarian and researcher at Imperial Chemical Industries (ICI), spent thirteen years developing propofol, an effort for which he was awarded the 2018 Lasker Award for clinical research. Originally developed as ICI 35868, propofol was chosen after extensive evaluation and structure–activity relationship studies of the anesthetic potencies and pharmacokinetic profiles of a series of ortho-alkylated phenols. First identified as a drug candidate in 1973, propofol entered clinical trials in 1977, using a form solubilized in cremophor EL. However, due to anaphylactic reactions to cremophor, this formulation was withdrawn from the market and subsequently reformulated as an emulsion of a soya oil and propofol mixture in water. The emulsified formulation was relaunched in 1986 by ICI (whose pharmaceutical division later became a constituent of AstraZeneca) under the brand name Diprivan. The preparation contains 1% propofol, 10% soybean oil, and 1.2% purified egg phospholipid as an emulsifier, with 2.25% glycerol as a tonicity-adjusting agent, and sodium hydroxide to adjust the pH. Diprivan contains EDTA, a common chelation agent that also acts alone (bacteriostatically against some bacteria) and synergistically with some other antimicrobial agents. Newer generic formulations contain sodium metabisulfite as an antioxidant and benzyl alcohol as an antimicrobial agent. Propofol emulsion is an opaque white fluid due to the scattering of light from the emulsified micelle formulation.
Metal nitrosyls, compounds featuring NO ligands, are numerous. In contrast to metal carbonyls, however, homoleptic metal nitrosyls are rare. NO is a stronger π-acceptor than CO. Well known nitrosyl carbonyls include CoNO(CO)3 and Fe(NO)2(CO)2, which are analogues of Ni(CO)4.
Sources: en.wikipedia.org
Liquid chromatography coupled with tandem mass spectrometry is widely used because it can separate NMN from related nucleotides and quantify low concentrations. Stable isotope-labeled internal standards help correct for matrix effects and recovery losses. Ultraviolet detection alone is less specific for complex biological matrices.
Research-grade NMN powder is commonly stored frozen, desiccated, and protected from light. Sealed containers at minus twenty degrees Celsius or below are typical. Allow containers to reach room temperature before opening to reduce condensation.
Purity is one quality attribute and does not by itself establish identity, safety, or absence of contaminants. A complete assessment includes structural confirmation, residual solvent testing, and microbial limits when relevant. Different analytical methods can yield different purity values.
NMN is often measured by high-performance liquid chromatography with ultraviolet detection. Liquid chromatography-tandem mass spectrometry can provide greater sensitivity and specificity. The chosen method should be validated and compared against a certified reference standard when possible.